Galera Therapeutics' GAAP loss for 9M 2021 was $63.727 million, up 17.7% from $54.152 million in the prior year.
Galera Therapeutics' GAAP loss for 9M 2021 was $63.727 million, up 17.7% from $54.152 million in the prior year.
Financial results
Galera Therapeutics' GAAP loss for 9M 2021 was $63.727 million, up 17.7% from $54.152 million in the prior year. Source: 
investors.galeratx.com
investors.galeratx.com
English (US) 